|
|
Autism Research Institute
Autism Research Review International
1987 to 2004, Volumes 1 to 18
N
N-acetyl-aspartate (NAA), 1999, Vol. 13(4) pp. 4
n-nitrosamines, 1998, Vol. 12(2) pp. 7
NAA (N-acetyl-aspartate), 1999, Vol. 13(4) pp. 4
NAAR (National Alliance for Autism Research), 2000, Vol. 14(4) pp. 3
Nadia (Selfe and Newsom), 1989, Vol. 03(1) pp. 1
nadolol, 1990, Vol. 04(3) pp. 7
NAFP (Neuron-Axon Filament Proteins), 1989, Vol. 03(4) pp. 1
Nakane, A., 1997, Vol. 11(1) pp. 1
naloxone. See also naltrexone
naltrexone
naltrexone (Trexan)
for aggression, 1989, Vol. 03(3) pp. 1; 1991, Vol. 05(3) pp. 4; 1991, Vol. 05(4) pp. 2; 1992, Vol. 06(1) pp. 2.
and arginine-vasopressin, 1996, Vol. 10(1) pp. 4
for attention, 1992, Vol. 06(1) pp. 1
and B-endorphins, 1996, Vol. 10(1) pp. 4
for communication, 1990, Vol. 04(4) pp. 4
and DMG, 1992, Vol. 06(2) pp. 2
dosage, 1992, Vol. 06(1) pp. 2; 1992, Vol. 06(2) pp. 2.
for focus, 1991, Vol. 05(4) pp. 2; 1992, Vol. 06(1) pp. 1; 1992, Vol. 06(2) pp. 2.
and haloperidol, 1992, Vol. 06(2) pp. 2
for hyperactivity, 1989, Vol. 03(3) pp. 1; 1991, Vol. 05(3) pp. 4; 1991, Vol. 05(4) pp. 2; 1992, Vol. 06(1) pp. 1; 1992, Vol. 06(2) pp. 2; 1995, Vol. 09(2) pp. 2; 1996, Vol. 10(3) pp. 6.
for language, 1989, Vol. 03(3) pp. 1; 1990, Vol. 04(4) pp. 4; 1992, Vol. 06(1) pp. 2; 1992, Vol. 06(2) pp. 2.
for obsessive-compulsive behaviors, 1995, Vol. 09(2) pp. 7
for opioid-caused symptoms, 1987, Vol. 01(2) pp. 1; 1989, Vol. 03(3) pp. 1; 1990, Vol. 04(2) pp. 1; 1990, Vol. 04(4) pp. 4; 1991, Vol. 05(3) pp. 4; 1993, Vol. 07(1) pp. 4; 1996, Vol. 10(1) pp. 4.
oxytocin theory, 1992, Vol. 06(3) pp. 4; 1996, Vol. 10(3) pp. 2.
panic attacks, 1990, Vol. 04(2) pp. 1
and peptides, 1992, Vol. 06(2) pp. 2
for play, 1992, Vol. 06(2) pp. 2
and Rett's, 1992, Vol. 06(1) pp. 2
for rumination, 1995, Vol. 09(2) pp. 7
for self-injury (See under self-injury)
side effects from, 1987, Vol. 01(2) pp. 1
for social withdrawal, 1990, Vol. 04(2) pp. 1; 1990, Vol. 04(4) pp. 4; 1991, Vol. 05(3) pp. 4; 1992, Vol. 06(1) pp. 1; 1992, Vol. 06(2) pp. 2; 1996, Vol. 10(3) pp. 5.
for stereotypies, 1989, Vol. 03(3) pp. 1; 1990, Vol. 04(4) pp. 4; 1992, Vol. 06(1) pp. 2; 1992, Vol. 06(2) pp. 2.
studies about, 1992, Vol. 06(1) pp. 2
and supplements, 1992, Vol. 06(2) pp. 2
for tantrums, 1989, Vol. 03(3) pp. 1; 1991, Vol. 05(3) pp. 4.
for tardive dyskinesia, 1992, Vol. 06(2) pp. 2
Nanson, J. L., 1992, Vol. 06(4) pp. 5
Naruse, Hiroshi, 1987, Vol. 01(4) pp. 6; 1990, Vol. 04(2) pp. 1; 1997, Vol. 11(4) pp. 4.
NASBE (National Association of State Boards of Education), 1993, Vol. 07(1) pp. 3
Nathanson, David, 1989, Vol. 03(4) pp. 2
National Academy of Sciences, 2000, Vol. 14(3) pp. 1
National Alliance for Autism Research (NAAR), 2000, Vol. 14(4) pp. 3
National Association of State Boards of Education (NASBE), 1993, Vol. 07(1) pp. 3
National Center for Complementary and Alternative Medicine, 2001, Vol. 15(1) pp. 7
National Childhood Vaccine Injury Act, 1990, Vol. 04(3) pp. 5; 1992, Vol. 06(3) pp. 6.
National Council for Improved Health, 1992, Vol. 06(2) pp. 3
National Education Association, 1995, Vol. 09(4) pp. 1
National Environmental Trust, 2000, Vol. 14(3) pp. 1
National Enzyme Company, 2002, Vol. 16(1) pp. 3
National Information System for Vietnam Veterans, 1992, Vol. 06(2) pp. 1; 1992, Vol. 06(3) pp. 2.
National Institute of Child Health and Development, 1988, Vol. 02(3) pp. 3
National Institute of Child Health and Development (NICHD), 1998, Vol. 12(4) pp. 3; 1999, Vol. 13(3) pp. 7.
National Institute of Environmental Health Sciences, 2000, Vol. 14(4) pp. 3
National Institute of Health (NIH)
autism research centers, 1997, Vol. 11(2) pp. 3
bribery scandal, 2004, Vol. 18(4) pp. 3
Consensus Development Conference on the Treatment of Destructive Behaviors, 1989, Vol. 03(4) pp. 1; 1990, Vol. 04(1) pp. 6; 1990, Vol. 04(4) pp. 3; 1992, Vol. 06(2) pp. 1.
database on complementary and alternative medicine, 2001, Vol. 15(1) pp. 7
and Office of Human Projects Protection, 2004, Vol. 18(2) pp. 6
omega-e-fatty acids' workshop, 1999, Vol. 13(1) pp. 7
questionnaire proposed by Bernard Rimland, 2003, Vol. 17(4) pp. 6
National Institute of Mental Health, 2001, Vol. 15(3) pp. 3
National Institute of Mental Health (NIMH), 2000, Vol. 14(3) pp. 3
National Longitudinal Transition Study of Special Education Students, 1995, Vol. 09(4) pp. 7
National Organizaton for Rare Disorders, 1991, Vol. 05(1) pp. 1
National Research Council, 2001, Vol. 15(3) pp. 6
National School Board Association, 1995, Vol. 09(4) pp. 1
National Vaccine Information Center, Dissatisfied Parents Together, 1990, Vol. 04(3) pp. 5; 1992, Vol. 06(3) pp. 6; 1995, Vol. 09(1) pp. 6; 1996, Vol. 10(1) pp. 3; 1999, Vol. 13(2) pp. 3; 1999, Vol. 13(3) pp. 7; 2001, Vol. 15(3) pp. 1; 2001, Vol. 15(4) pp. 1.
natural killer (NK) cells, 1987, Vol. 01(2) pp. 2; 1992, Vol. 06(2) pp. 2.
Natural Language Paradigm (NLP), 1989, Vol. 03(2) pp. 5
"natural pointer" task, 1996, Vol. 10(1) pp. 6
Nebraska, 2004, Vol. 18(4) pp. 3
nefazadone (Serzone), 2004, Vol. 18(1) pp. 9; 2004, Vol. 18(3) pp. 6.
negative attention, 1988, Vol. 02(3) pp. 6
negative placebo effect, 2000, Vol. 14(2) pp. 3
negative practice, 1987, Vol. 01(2) pp. 5
negative symptoms, 1997, Vol. 11(3) pp. 4
negative teaching examples, 1987, Vol. 01(4) pp. 5
Nelson, Courtney, 2002, Vol. 16(1) pp. 6–7
Nelson, David, 1991, Vol. 05(2) pp. 1
Nelson, Karin B., 1995, Vol. 09(1) pp. 4; 2000, Vol. 14(2) pp. 1.
Neo Mull Soy study, 1989, Vol. 03(1) pp. 6; 1990, Vol. 04(2) pp. 6.
neocortex, 2003, Vol. 17(2) pp. 2
nerve cells, 1994, Vol. 08(1) pp. 4; 2003, Vol. 17(3) pp. 1.
nerve growth factor (NGF), 1989, Vol. 03(3) pp. 7
Neubrander, Jim A., 2004, Vol. 18(3) pp. 3
neural tube defects
folic acid for, 1989, Vol. 03(2) pp. 4; 1992, Vol. 06(3) pp. 5; 1995, Vol. 09(4) pp. 5.
inositol as preventive, 1997, Vol. 11(2) pp. 2
thalidomide and, 1989, Vol. 03(2) pp. 4; 1997, Vol. 11(3) pp. 1.
vitamin C deficiency and, 1989, Vol. 03(2) pp. 4
Neurobiology of Infantile Autism (Naruse and Ornitz), 1992, Vol. 06(2) pp. 7
neurocutaneous disorders, 1998, Vol. 12(1) pp. 4
neurofeedback therapy, 1996, Vol. 10(2) pp. 4; 1996, Vol. 10(4) pp. 6; 2003, Vol. 17(1) pp. 2.
neurofibrillary tangles, 1992, Vol. 06(2) pp. 4
neurofibromatosis, 1988, Vol. 02(1) pp. 1; 1996, Vol. 10(3) pp. 5.
neuroleptic malignant syndrome
and drugs, 1994, Vol. 08(1) pp. 1; 1996, Vol. 10(3) pp. 2; 1997, Vol. 11(1) pp. 2; 1997, Vol. 11(2) pp. 7; 1997, Vol. 11(3) pp. 2; 1998, Vol. 12(2) pp. 4; 2000, Vol. 14(2) pp. 4.
supplements for, 1998, Vol. 12(4) pp. 6
neuroleptics, 2000, Vol. 14(1) pp. 4
neuromuscular diseases, 1999, Vol. 13(3) pp. 4; 2003, Vol. 17(3) pp. 4.
neuron-axal filament 200-Kd protein, 2004, Vol. 18(4) pp. 4
Neuron-Axon Filament Proteins (NAFP), 1989, Vol. 03(4) pp. 1
neuronal connections, 2001, Vol. 15(2) pp. 1
neurons, 2003, Vol. 17(3) pp. 1
neuropathy, 2001, Vol. 15(3) pp. 7
neuropathy target esterase (NTE), 2003, Vol. 17(1) pp. 6
neuropil, 2002, Vol. 16(1) pp. 1
neurotransmitters. See also individual entries
and 5-HTP, 1999, Vol. 13(1) pp. 2
acetylcholine, 1998, Vol. 12(4) pp. 2; 2001, Vol. 15(3) pp. 7; 2002, Vol. 16(4) pp. 5; 2004, Vol. 18(2) pp. 5.
beta-endorphin, 1990, Vol. 04(4) pp. 4; 1991, Vol. 05(1) pp. 4.
CB1 receptor, 2003, Vol. 17(4) pp. 4
dopamine (See dopamine)
GABA, 1997, Vol. 11(4) pp. 7; 1998, Vol. 12(4) pp. 6; 2001, Vol. 15(4) pp. 2; 2003, Vol. 17(1) pp. 6; 2004, Vol. 18(2) pp. 2.
GABRB 1989, Vol. 03(1) pp. 6
glutamate, 2003, Vol. 17(2) pp. 2
glutamine, 2001, Vol. 15(4) pp. 2
histamine, 2001, Vol. 15(2) pp. 6
inhibitory and vagus nerve stimulators, 1997, Vol. 11(4) pp. 2
L-carnosine for modulation of, 2003, Vol. 17(1) pp. 1
noradrenalin, 1989, Vol. 03(4) pp. 4; 1994, Vol. 08(4) pp. 4.
norepinephrine, 1989, Vol. 03(2) pp. 4; 2000, Vol. 14(2) pp. 4; 2001, Vol. 15(2) pp. 2; 2004, Vol. 18(3) pp. 6.
peptides as false neurotransmitters, 2002, Vol. 16(1) pp. 7
and R-THBP, 1995, Vol. 09(3) pp. 4
serotonin (See serotonin)
and tetanus neurotoxins, 1998, Vol. 12(4) pp. 6
tryptophan, 1991, Vol. 05(3) pp. 1; 1996, Vol. 10(1) pp. 6; 1996, Vol. 10(4) pp. 6; 1997, Vol. 11(4) pp. 4; 1999, Vol. 13(1) pp. 2; 1999, Vol. 13(4) pp. 4.
and vitamin B6, 1994, Vol. 08(1) pp. 2; 2004, Vol. 18(4) pp. 4.
nevi, atypical, 1998, Vol. 12(1) pp. 4
Neville, B.G. R., 1995, Vol. 09(2) pp. 1; 1997, Vol. 11(3) pp. 4.
New Atlantean Press catalog, 2003, Vol. 17(2) pp. 4
New England Journal of Medicine, 1988, Vol. 02(4) pp. 1; 2004, Vol. 18(3) pp. 5.
New Hope Foundation, 1997, Vol. 11(3) pp. 7
New Jersey, 2004, Vol. 18(2) pp. 3
New York, 2004, Vol. 18(4) pp. 3
Newhart-Larson, Sue, 1990, Vol. 04(1) pp. 4
Newman, Bobby, 2000, Vol. 14(3) pp. 5
News from the Border (McDonnel), 1993, Vol. 07(3) pp. 1
newsletters, 1994, Vol. 08(2) pp. 6
Newsom, Crighton D., 1987, Vol. 01(1) pp. 5; 1990, Vol. 04(4) pp. 5.
Newsom, Elizabeth, 1989, Vol. 03(1) pp. 2
Newson, Elizabeth, 2003, Vol. 17(4) pp. 6
Ney, Philip G., 1990, Vol. 04(1) pp. 2
NH2, 1997, Vol. 11(4) pp. 4
niacin, 1999, Vol. 13(4) pp. 4
niacinamide (vitamin B3), 1992, Vol. 06(2) pp. 7; 1998, Vol. 12(3) pp. 7.
nickel poisoning, 2002, Vol. 16(3) pp. 4
Nicolson, Rob, 1998, Vol. 12(2) pp. 4
nicotinamide dicnucleotide (NAD), 1999, Vol. 13(4) pp. 4
nicotine
for ADHD, 1998, Vol. 12(4) pp. 2
for depression, 1998, Vol. 12(4) pp. 2
mecamylamine for Tourette's, 1998, Vol. 12(3) pp. 4
and n-nitrosamines, 1998, Vol. 12(2) pp. 7
for schizophrenia, 1998, Vol. 12(4) pp. 2
for Tourette's, 1998, Vol. 12(2) pp. 1; 1998, Vol. 12(4) pp. 2.
nicotinic receptors, 2001, Vol. 15(3) pp. 7
Nieto, Natalia, 2002, Vol. 16(2) pp. 4
night blindness, 2000, Vol. 14(4) pp. 6
NIH. See National Institute of Health
Nikolskaya, O. S., 1988, Vol. 02(3) pp. 7
Nizoral (ketoconosal), 1988, Vol. 02(2) pp. 3; 1996, Vol. 10(3) pp. 4.
NK (natural killer) cells, 1987, Vol. 01(2) pp. 2; 1992, Vol. 06(2) pp. 2.
NMDA glutamatergic receptors, 2001, Vol. 15(4) pp. 2
No-Fenol, 2002, Vol. 16(1) pp. 3
Noakes, Jeremy, 1996, Vol. 10(2) pp. 1
Nobody Nowhere (Williams), 1994, Vol. 08(1) pp. 6–7
noise-cancelling headset, 2002, Vol. 16(1) pp. 7
nomercury.org, 2004, Vol. 18(4) pp. 3
non-aversives. See also aversives
aversives' opponents, 1994, Vol. 08(1) pp. 1; 1994, Vol. 08(3) pp. 6.
choice-making, 1994, Vol. 08(1) pp. 2
court cases for SIBIS use, 1989, Vol. 03(4) pp. 3
functional communication, 1994, Vol. 08(1) pp. 2
Gentle Teaching, 1989, Vol. 03(3) pp. 1–2
reinforcing incompatible behaviors, 1989, Vol. 03(1) pp. 5
self-monitoring, 1994, Vol. 08(1) pp. 2
TASH (The Association for Persons with Severe Handicaps) monograph on, 1990, Vol. 04(2) pp. 6; 2001, Vol. 15(4) pp. 3.
non-organic autism, 1988, Vol. 02(2) pp. 5
noncontingent reinforcement (NCR), 1999, Vol. 13(4) pp. 5
nonsteroidal anti-inflammatory drugs (NSAIDs), 2000, Vol. 14(3) pp. 5; 2001, Vol. 15(1) pp. 4.
noradrenaline, 1994, Vol. 08(4) pp. 4; 2004, Vol. 18(3) pp. 6.
norepinephrine, 1989, Vol. 03(2) pp. 4; 2000, Vol. 14(1) pp. 4; 2000, Vol. 14(2) pp. 4; 2001, Vol. 15(2) pp. 2; 2004, Vol. 18(2) pp. 5.
normal autistics, 1988, Vol. 02(2) pp. 5
Norplant, 1995, Vol. 09(4) pp. 4; 1996, Vol. 10(2) pp. 4; 2003, Vol. 17(1) pp. 4.
North Carolina, 2004, Vol. 18(4) pp. 3
nortriptyline, 1995, Vol. 09(3) pp. 4
Norwood, Caroline P., 1997, Vol. 11(2) pp. 6
Novak, Richard John, 2000, Vol. 14(4) pp. 7
Novartis, 2002, Vol. 16(1) pp. 4
Novellino, Ettore, 2003, Vol. 17(1) pp. 7
Nowell, Martha Ann, 1991, Vol. 05(2) pp. 4
NSAIDs (nonsteroidal anti-inflammatory drugs), 2000, Vol. 14(3) pp. 5; 2001, Vol. 15(1) pp. 4.
Nsouli, T. M., 1997, Vol. 11(1) pp. 7
NTE (neuropathy target esterase), 2003, Vol. 17(1) pp. 6
Null, Gary (radio talk show host), 1997, Vol. 11(4) pp. 3
Nutriguard, 1995, Vol. 09(1) pp. 6
Nutrition Care Guidelines for Rett Syndrome (Rice), 1989, Vol. 03(4) pp. 7
nutrition in group homes, 1993, Vol. 07(2) pp. 2
Nutritional Health Alliance, 1992, Vol. 06(2) pp. 3
nutritional therapy, 2004, Vol. 18(4) pp. 7. See diets, supplements
for autistics, 1987, Vol. 01(4) pp. 3; 1993, Vol. 07(3) pp. 6; 1995, Vol. 09(2) pp. 3; 1997, Vol. 11(3) pp. 1.
for behaviors, 2004, Vol. 18(4) pp. 6
for candida-caused infections, 1989, Vol. 03(1) pp. 6
for cardiac longevity, 1997, Vol. 11(3) pp. 3
and early intervention, 1995, Vol. 09(4) pp. 6
for Rett's, 1987, Vol. 01(2) pp. 7; 1995, Vol. 09(4) pp. 6.
for schizophrenia, 1988, Vol. 02(3) pp. 4
Nystatin, 1988, Vol. 02(2) pp. 3; 1988, Vol. 02(4) pp. 6.
Nytol, 2003, Vol. 17(1) pp. 5
© copyright 2005, 2006 Autism Research Institute
|
|
